The company raised $51.49 million of Series A venture funding in a deal led by Monsanto Growth Ventures, B Capital Group and Data Collective on July 2, 2018, putting the company's pre-money valuation at $120 million. Baidu Ventures, Tencent Holdings, Khosla Ventures, Dolby Family Ventures, Draper Fisher Jurvetson Management, Vickers Venture Partners and Y Combinator also participated in the round. The funds will be used to seek new collaborators to address global health challenges using artificial intelligence and grow their technical and business organization.
Leave a Reply ·
You must be logged in to post a comment.